Scott Wolchko | President & Chief Executive Officer |
Ed Dulac | Chief Financial Officer |
Bob Valamehr | Chief Research & Development Officer |
Jack Allen | Baird |
Welcome to the Fate Therapeutics Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in listen-only mode. This call is being webcast live on the Investors section of Fate's website at fatetherapeutics.com.
As a reminder, today's call is being recorded.
I would now like to introduce Scott Wolchko, President and CEO of Fate Therapeutics.